nad has been researched along with metoprolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, K; Li, Q; Lu, S; Ma, T; Tang, S; Wu, M; Yang, H; Zhong, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 other study(ies) available for nad and metoprolol
| Article | Year |
|---|---|
Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1/p53/p21 Axis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylation; Adrenergic beta-1 Receptor Antagonists; Animals; Arginine Vasopressin; Cell Line; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cytokines; DNA Damage; Metoprolol; Myocytes, Cardiac; NAD; NADP; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Protein Processing, Post-Translational; Rats; Signal Transduction; Sirtuin 1; Telomerase; Tumor Suppressor Protein p53 | 2022 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |